Ghost Fitness/Collagen/Can you take collagen if you have keloids?
Can you take collagen if you have keloids?
The short answer
Nothing in the biology or literature says no. A keloid is a local signalling problem: fibroblasts in one patch over-respond to wound signals. Eaten collagen is amino acid supply, which those fibroblasts already have. No trial exists; ask your dermatologist.
- The keloidfibroblasts in a wound over-respond to transforming growth factor beta and other signals, depositing disorganised collagen beyond the wound's edges; genetics, skin type and site drive it
- The treatmentsintralesional corticosteroid, silicone, pressure, cryotherapy, laser, surgery only with adjuncts; all act on local signalling and deposition
- Eaten collagendigested to amino acids and small peptides joining the general pool; a fibroblast draws glycine and proline from that pool whatever protein was eaten; supply, not signal
- The literaturedietary protein and collagen intake not identified as a cause or aggravating factor; no trial of collagen supplements in keloid-prone people
Our brand: the worked example on this page
Futuro Labs Marine Collagen
- 28p a day
- 120 capsules, 2 capsules daily
- Lab tested
- Made in the UK
The worked example, with its label read by the reader's dermatologist if keloids are active, on its true terms: Futuro Labs Marine Collagen on Amazon UK, 2 capsules, 1200mg hydrolysed type 1 marine collagen with 12mg vitamin C at 15% NRV plus zinc, 120 for £16.99, 28p a day, lab tested and UK made, holding no skin or scar claim. Full label breakdown. The same logic for scleroderma is on the scleroderma page; the safety record on the is collagen safe page; the body's own overproduction conditions on the producing too much collagen page.
Supply and signal: what a keloid is, why every treatment acts on the signal, and what eaten collagen is
Can you take collagen if you have keloids is one of the most sensible worries a reader brings to a collagen supplement, because a keloid is made of collagen, too much of it, and the instinct that eating more collagen might feed it is the instinct of someone who has understood what a keloid is; the honest page respects the worry and answers it by separating two words that it runs together, supply and signal. Start with the keloid. When skin is wounded, by a cut, a piercing, acne, a burn, a surgical incision or a vaccination, fibroblasts arrive at the wound and deposit collagen in response to transforming growth factor beta and the other signalling molecules of wound healing, and in most people the signals switch off as the wound closes, the deposition stops and the scar flattens over the following year. In a keloid-prone person the fibroblasts in that patch of skin over-respond to the same signals, deposit far more collagen than the wound needs, deposit it in thick, disorganised, whorled bundles rather than the orderly basket-weave of normal dermis, and keep depositing beyond the edges of the original wound for months or years, producing the raised, firm, often itchy or tender scar that is a keloid and that distinguishes it from a hypertrophic scar, which stays within the wound's edges and tends to settle. What drives the over-response is local and inherited: keloids run in families, occur at much higher rates in darker skin, and favour particular sites, the chest, the shoulders and upper back, the earlobes and the jawline, so that the same person may form a keloid on the chest and a flat scar on the forearm, which is itself the proof that the problem is in the fibroblasts of that patch rather than in anything circulating through the whole body. Every treatment that works acts on that local signalling and deposition. Corticosteroid injected directly into the scar suppresses the fibroblasts' collagen synthesis and softens and flattens the keloid over a course of injections. Silicone sheets and gels worn over the scar for months reduce its growth by mechanisms that are still debated. Pressure garments and pressure earrings after earlobe keloid surgery do the same. Cryotherapy freezes the scar tissue. Lasers target its vessels and its bulk. And surgery alone is avoided, because cutting out a keloid creates a new wound in keloid-prone skin and the signalling restarts, often producing a larger keloid than the one removed, so excision is combined with injected steroid, radiotherapy or pressure to suppress the response. Now the collagen supplement. Eaten collagen, whether marine or bovine, hydrolysed or gelatin, is a protein, and the gut treats it as it treats every protein: the enzymes of the stomach and small intestine cut it into amino acids and short peptides of two or three amino acids, which are absorbed into the blood and join the body's general amino acid pool, the same pool that every meal's protein joins and from which every cell in the body draws what it needs. The collagen supplement is a supply of glycine, proline and hydroxyproline to that pool, and a supply is not a signal.
Why supply does not drive a keloid, what the literature does and does not say, the three-part honest answer, and the worked example
The reason supply does not drive a keloid is that a keloid fibroblast is not short of anything. The glycine, proline and hydroxyproline that collagen is made from are among the most abundant amino acids in the body, made by the body itself from other amino acids as well as eaten, and a fed person's amino acid pool contains far more of them than any fibroblast could use; a fibroblast that is overproducing collagen in a keloid is doing so because of the signal it is receiving and over-responding to, not because the supply of raw material has risen, and it would overproduce at the same rate on a diet of eggs, chicken or lentils, all of which supply the same amino acids through the same pool. The same separation answers the scleroderma worry, in which the whole body's fibroblasts are driven by an autoimmune signal, on the scleroderma page, and the body's own overproduction conditions, from keloids through Dupuytren's to frozen shoulder, are set out by site on the producing too much collagen page, all of them signalling conditions in which supply plays no part. What the literature says is consistent with the biology: the keloid pathogenesis and treatment literature, which is large, has not identified dietary protein intake or oral collagen as a cause, a risk factor or an aggravating factor for keloid formation or growth, and the dietary factors it does discuss are speculative and unrelated to protein. What the literature does not say is the other half of the honest answer: no trial has enrolled keloid-prone people and given them collagen supplements to measure what happens to their scars, because no one has had a reason to run one, so there is no direct evidence of safety to point to either, only the absence of any signal of harm in a condition that has been studied for a century and a biology that gives no route by which harm would occur. The collagen safety record in general, trials dosing daily for up to a year with adverse events no different from placebo, is on the is collagen safe page, and none of those trials excluded or reported on keloid-prone participants. The honest answer therefore has three parts and the page gives all three rather than the comfortable two. Nothing in the biology or the literature says no: a keloid is a local signalling problem and eaten collagen is systemic amino acid supply, and the two do not meet. No trial has enrolled keloid-prone people to say yes with data: the reassurance is from mechanism and from absence of any signal, not from a trial designed to find one. And a reader with active or growing keloids, or one facing surgery, a piercing or a procedure at a keloid-prone site, asks the dermatologist treating them before adding any supplement, because that dermatologist knows the scar, its activity and the treatment plan, and because a reader whose keloid changes while taking anything new will want to have had that conversation first; the dermatologist may also have views on the vitamin C and zinc in a collagen capsule, both involved in wound healing at sufficiency and neither a keloid driver, and on the fish source for anyone with a fish allergy. The worked example is stated on its true terms: two capsules, 1200mg hydrolysed type 1 marine collagen with 12mg vitamin C at 15% of its reference value plus zinc, 120 for £16.99 at 28p a day, lab tested and UK made, at a dose below the 2.5 to 10g skin trials and carrying vitamin C's collagen formation sentence for normal skin function and no scar, keloid or healing claim, with the label read by the reader's dermatologist if keloids are active. Can you take collagen if you have keloids: the biology and the literature give no reason not to, no trial gives a reason to be certain, and the dermatologist who treats the keloids is the person to ask.
| The question | The keloid side: signal | The supplement side: supply | What follows |
|---|---|---|---|
| What is it | Fibroblasts in one patch of skin over-respond to wound signals and deposit disorganised collagen beyond the wound | A protein digested to amino acids and small peptides joining the body's general pool | A local signalling problem and a systemic supply do not meet |
| What drives it | Genetics, skin type, site: chest, shoulders, earlobes, jaw; the same person scars flat elsewhere | Nothing: supply does not instruct a fibroblast | A fibroblast overproduces at the same rate on eggs, chicken or lentils |
| What treats it | Intralesional corticosteroid, silicone, pressure, cryotherapy, laser, surgery with adjuncts | Not a treatment and not a cause | Every effective treatment acts on the signal or the deposition |
| What the literature says | Dietary protein and collagen intake not identified as a cause or aggravating factor | Daily dosing for up to a year with placebo-level adverse events; keloid status not reported | No signal of harm; no trial designed to find one |
| Hypertrophic scar | Stays within the wound's edges and tends to settle; the same supply logic applies | As above | Ask the dermatologist if a scar is active |
| Active or growing keloids, or a procedure at a prone site | The dermatologist knows the scar and the plan | Vitamin C and zinc in the capsule are wound-healing cofactors at sufficiency, not keloid drivers | Ask before adding any supplement |
| Fish allergy | Not a keloid question | Marine collagen is a fish-derived protein | Excluded for fish allergy at any dose |
| The worked exampleOurs | No scar, keloid or healing claim | Two capsules, 1200mg marine collagen with 12mg vitamin C plus zinc, 28p a day; below the 2.5 to 10g skin trials | Label read by the dermatologist if keloids are active |
What to check on the label
- Separate supply from signal: a keloid is a local signalling problem.
- Know what eaten collagen is: amino acid supply to a pool every protein joins.
- Read the literature's two halves: no signal of harm; no trial in keloid-prone people.
- Ask the dermatologist if keloids are active: or before a procedure at a prone site.
- State the worked example on its true terms: 1200mg, no scar or healing claim, excluded for fish allergy.
Our brand
The worked example: Futuro Labs Marine Collagen
Futuro Labs Marine Collagen: 2 capsules daily, 1200mg hydrolysed type 1 marine collagen with 12mg vitamin C and 1.5mg zinc (15% NRV each), 120 capsules for £16.99, 60 days at 28p a day, lab-tested, UK GMP made. Slim veggie-shell capsules, odour free. Fish derived: pescatarian, not vegetarian or vegan.
- Collagen per serving
- 1200mg hydrolysed type 1 marine (fish)
- Co-factors
- vitamin C 12mg (15% NRV), zinc 1.5mg (15% NRV)
- Serving
- 2 capsules a day
- Bottle
- 120 capsules, 60 days
- Price
- £16.99 (28p a day)
- Capsule
- slim size 00, veggie shell, odour free
Questions people also ask
Does collagen make keloids worse?
Nothing in the biology or the keloid literature says so: a keloid is driven by fibroblasts in one patch of skin over-responding to wound signals, and eaten collagen is digested to amino acids that join the body's general pool, from which those fibroblasts already draw all the glycine and proline they could use from any protein eaten; dietary protein and collagen intake have not been identified as a cause or aggravating factor.
Can collagen supplements cause keloids?
No route exists for it to: keloid formation needs a wound in keloid-prone skin and the over-response of that skin's fibroblasts to local signals, set by genetics, skin type and site, and a supply of amino acids through the blood instructs no fibroblast to deposit collagen; a reader who forms keloids on the chest and flat scars on the forearm has the proof that the problem is local rather than circulating.
Should I avoid collagen if I am prone to keloids?
The biology and the literature give no reason to, and no trial gives data either way, since none has enrolled keloid-prone people on collagen supplements; the honest course is to ask the dermatologist who treats the keloids if any are active or growing, or before a piercing, surgery or procedure at a keloid-prone site, and otherwise to treat the supplement as the food protein it is.
Is collagen good for scars?
No trial has tested oral collagen on scars, keloid or otherwise: the skin trials measured elasticity and hydration by instrument in unscarred skin at 2.5 to 10g a day, and the interventions with evidence for scars act locally, silicone, pressure, injected corticosteroid for keloids and hypertrophic scars, so a collagen capsule holds no scar or healing claim and the worked example carries none.
What should I tell my dermatologist about collagen supplements?
The dose, the source and the passengers: the worked example is 1200mg of hydrolysed marine collagen a day with 12mg vitamin C and zinc, a fish-derived protein below the 2.5 to 10g skin trial doses, so the dermatologist can note the fish source for allergy, the vitamin C and zinc as wound-healing cofactors at sufficiency, and the absence of any keloid signal in the literature, and advise against the background of the scar's activity and treatment plan.
Sources
- The keloid biology literature: keloids are raised scars that grow beyond the original wound, driven by fibroblasts in the affected skin that over-respond to transforming growth factor beta and other wound signals and deposit excess, disorganised collagen, with strong genetic and site predisposition, higher rates in darker skin and on the chest, shoulders, ears and jaw; treatments act on the local signalling and deposition, intralesional corticosteroid, silicone sheeting, pressure, cryotherapy, laser and surgery with adjuncts, and dietary protein or oral collagen intake has not been identified as a cause or aggravating factor in the keloid literature. PubMed record
- The systemic sclerosis literature: scleroderma is an autoimmune disease in which immune activation drives fibroblasts to deposit excess collagen in skin and organs, with no dietary cause and no relationship to collagen intake, and oral bovine type I collagen was tested as a treatment in a randomised placebo-controlled trial on the principle of oral tolerance, without meeting its primary endpoint, so that collagen has been studied in scleroderma as a candidate therapy and never as a cause. PubMed record
- The collagen biology literature: collagen is the most abundant protein in the body, around a quarter to a third of total protein, with type I forming the fibres of skin, tendon, ligament and bone, type II the cartilage matrix and type III the finer fibres of skin, vessels and healing tissue, made by fibroblasts and related cells from glycine, proline and lysine, hydroxylated with vitamin C as the enzyme cofactor, and turned over on timescales from months to years by tissue. PubMed record
- The oral collagen safety record: hydrolysed collagen has been given at 2.5 to 15 grams a day in trials of up to a year with adverse events no different from placebo, is consumed in gram quantities from meat, skin and gelatin in ordinary diets, carries no tolerable upper intake level because it is a food protein rather than a nutrient with toxicity, and the recorded cautions are allergy to the source animal and the hydroxyproline to oxalate pathway in those who form calcium oxalate stones. PubMed record